InnovationRx: Autoimmune Therapies Boom, AI Enters Healthcare
The autoimmune therapy market is undergoing a massive capital reallocation as Vertex Pharmaceuticals (NASDAQ: VRTX) acquires Crinetics Pharmaceuticals (NASDAQ: CRC) for $10 billion. This consolidation, paired with OpenAI’s healthcare integration, ... Read More